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The glycoxidation product, N
ε
-(carboxymethyl)lysine (CML), is formed during reaction of glucose with 
protein under oxidative conditions. The aim of the study was to evaluate the levels of the most common 
glycoxidation product; N
ε
-(carboxymethyl)lysine (CML) and the most advanced lipoxidation product, 
malondialdehyde (MDA) in type 2 diabetic Malay, Indian, and Chinese ethnic groups in the Malaysian 
population. Studies were performed on age-matched Malay, Indian, and Chinese subjects with type 2 
diabetes mellitus. Different biochemical parameters including serum levels of CML, MDA, lipid profile, 
glucose, and hemoglobin A1c (HbA1c) were measured by standard methods. The relationships between 
circulating CML and lipids, HbA1c, and MDA, were examined. Correlation studies between CML, lipids, 
HbA1c, and lipid peroxidation were performed. CML and MDA levels were significantly higher in Malay 
subjects than in Indian or Chinese patients (p <0.005). A significant difference was also observed in the 
levels of serum total cholesterol and LDL-cholesterol (p <0.05) between the groups in the study. A 
positive correlation was observed between serum levels of CML and MDA in Malay diabetic patients, but 
no such correlation was seen in either the Chinese or Indian populations. The results of this study 
demonstrate that ethnicity affects CML and MDA circulating levels in Malaysian subjects with type 2 
diabetes mellitus. 
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INTRODUCTION  
 
Type 2 diabetes is the most common form of diabetes 
comprising 80 to 90% of all diabetic people. Type 2 
diabetes mellitus (T2DM) is a global health problem 
affecting approximately 4.0% of adults in the world in 
1995 (Harris et al., 1998) and this prevalence has been 
projected to increase to 5.4% by 2025 (King et al., 1998). 
Epidemiological data have considered hyperglycemia to 
be a major player in the development of macrovascular 
complications such as coronary artery disease (CAD) and 
stroke (Laakso,  1999).  Macrovascular  complications  of  
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diabetes mellitus (DM) are due to accelerated athero-
sclerosis and have an important role in the increased 
morbidity and mortality suffered by these individuals 
(Wingard and Barrett-Connor, 1995). For example, a 
recent meta-analysis study showed that the rate of fatal 
CAD is higher in diabetic patients than
 
in non-diabetic 
individuals (5.4% vs. 1.6%) (Huxley et al., 2006). 
Diabetes causes oxidative stress, not only due to the 
increased production of mitochondrial reactive oxygen 
species (ROS) or an impaired endogenous capacity to 
scavenge free radicals (Brownlee, 2001), but also due to 
glucose auto-oxidation (Wolff et al., 1991), and to the 
non-enzymatic glycation of proteins (Brownlee, 2000). In 
vivo glycation and lipid peroxidation reactions may play  a  
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central role in diabetic complications. The glycoxidation 
product, N
ε
(carboxymethyl)lysine (CML), is one of the 
major advanced glycation end products (AGEs) that 
forms under oxidative conditions (Bierhaus et al., 1998; 
Wells-Knecht et al., 1996). Ahmed et al. (2008) have 
shown the significant predictive power of high serum 
CML concentrations to the development of CAD in type 2 
diabetes patients. They also reported that the association 
between CML and CAD is independent of other risk 
factors. 
The International Diabetes Federation predicts that, by 
2025, the South East Asia Region will have an estimated 
diabetes prevalence of 7.5% (81.6 million) and an 
impaired glucose tolerance prevalence of 13.5% (120.5 
million) people (Sicree et al., 2003). It has been found 
that ethnicity affects the morbidity and mortality 
associated with diabetes mellitus (Gu et al., 1998; Shaw 
et al., 1999; Saydah et al., 2001; Lowe et al., 1997). Of 
several studies that have assessed the risk of mortality 
associated with diabetes (Shaw et al., 1999; Saydah et 
al., 2001; Wei et al., 1998; Schernthaner, 1996), only one 
(Shaw et al., 1999) included significant numbers of 
Southeast Asians. The elucidation of these ethnic 
differences may be particularly relevant in Asia, since the 
region will experience the greatest increase in diabetes 
mellitus prevalence over the next 5 to 10 years (Zimmet 
et al., 2001).  
According to the National Health and Morbidity Surveys 
of Malaysia, the prevalence of diabetes mellitus 
increased from 6.3% in 1986 (Public Health Institute, 
1986) to 8.2% in 1996 (Public Health Institute, 1996), and 
to more than 10% in 2006 (Public Health Institute, 2006). 
Based on that prevalence rate, the estimated number of 
diabetic patients in Malaysia is 2.6 million, indicating that 
Malaysian individuals have a tendency to develop 
diabetes with prevalence variations among Malaysian 
ethnic groups.  
Several studies have shown the higher prevalence of 
type 2 diabetes among Malays (Ali et al., 1993) and that 
obesity may be a more common feature of type 2 
diabetes in Malays than in other Asian groups (Pan et al., 
2004). In addition, a variety of studies in support of 
previous observations indicate that, Malays have a 
relatively high prevalence of the metabolic syndrome and 
type 2 diabetes compared with other Asian ethnic groups 
(Pan et al., 2004; Lim et al., 2000). 
The population of Malaysia comprises three major 
ethnic groups: Malays, Indians, and Chinese. Therefore, 
Malaysia presents a good example to study the effect of 
ethnicity variations in the propensity to oxidative stress 
and CML formation, and subsequently the increased 
propensity to develop macrovascular complications in 
patients with T2DM. The aim of the present study is to 
determine whether or not ethnicity modifies advanced 
glycation, lipid peroxidation and the risk factors of 
macrovascular complications associated with type 2 
diabetes mellitus among Malays, Chinese, and Indians 
living in Malaysia. 
 
 
 
 
MATERIALS AND METHODS  
 
Study population 
 
This study was conducted on 171 patients with type 2 diabetes 
mellitus; 63 Malay, 58 Indian, and 50 Chinese participants. The 
patients were matched for age, gender, glucose levels, and 
diabetes duration. Smokers and former smokers as well as subjects 
with known hepatic diseases, diabetes complications, or under 
antioxidant medication were excluded from this study. Plasma and 
serum samples were obtained from patients who regularly attend 
the Diabetes Clinics at the University of Malaya Medical Centre. 
Type 2 DM was considered to be present if the fasting blood 
glucose was ≥7.0 mmol/L, the 2 h blood glucose in the oral glucose 
tolerance test (OGTT) was ≥11.1, and/or the patient is using 
glucose-lowering medication (WHO, 1999). A signed consent form 
was obtained from all patients prior to their inclusion in the study. 
The study was approved by the Faculty of Medicine, University of 
Malaya Medical Ethics Committee, and the local ethics committee 
for animal experimentation in the Faculty of Medicine, University of 
Malaya. 
 
 
CML and malondialdehyde measurements 
 
Polyclonal anti-CML antibodies were developed in female New 
Zealand white rabbits according to the method described by Ikeda 
et al. (1996) and these antibodies were used for the measurement 
of serum CML by competitive enzyme-linked immunosorbent assay 
(ELISA) in duplicates according to the method used by Makita et al. 
(1992) as described in our previous work (Ahmed et al., 2007). The 
absorbance at 405 nm was read using an ELISA reader (MRX 
Microplate Reader, Dynatech Laboratories Ltd, UK). The amount of 
plasma malondialdehyde (MDA), an index of lipid peroxidation, was 
spectrophotometrically determined by the thiobarbituric acid 
reactive substances (TBARS) method as previously described 
(Ohkawa et al., 1979). The measurements were performed in 
duplicates and the optical density of pink color developed in the test 
reaction was measured by spectrophotometer against distilled 
water as blank at 532 nm. MDA standard was prepared from acid 
hydrolysis of 1,1,3,3-tetraethoxypropane (TEP)  according to the 
method of Tsaknis et al. (1998) with modifications. This stock-
standard solution, freshly prepared every day, was used for the 
preparation of standards of malondialdehyde.   
 
 
Other measurements 
 
Glucose levels were measured using the hexokinase-glucose-6-
phosphate dehydrogenase UV-method, in accordance with Kunst et 
al.’s (1983) method. HDL cholesterol, triglyceride and total 
cholesterol levels were measured by enzymatic methods using the 
Dimension Clinical Chemistry System (Dade Behring Inc., Newark, 
USA).  LDL cholesterol was calculated according to Friedewald 
formula (Friedewald et al., 1972). Percent HbA1c was determined by 
COBAS INTEGRA systems (Roche diagnostics, F. Hoffmann-La 
Roche Ltd, Basel, Switzerland) according to the manufacturer’s 
instructions.  
 
 
Statistical analysis 
 
All data were checked for normality and expressed as the 
mean±standard deviation (SD). Chi-square (X2) test was used for 
the analysis of categorical variables. Differences between groups in 
the mean values were assessed using one-way analysis of 
variance (ANOVA) followed by Bonferroni’s Post Hoc test to adjust 
the multiple comparisons. When data were not normally  distributed,  
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Table 1. Comparison of demographic and biochemical parameters in the study of ethnic groups.   
 
 Malays (n=63) Chinese (n=50) Indians (n=58) P value * 
Gender (male/female) 29/34 23/27 30/28 NS 
Age (years) 45.1 ± 15.1 44.9 ± 18.8 47.3 ± 18.4 NS 
Diabetes duration (years) 6.4 ± 3.1 6.8 ± 2.9 5.6 ± 2.4 NS 
Diastolic blood  pressure (mmHg) 78.7 ± 8.5 76.1 ± 7.3 75.7 ± 6.1 NS 
Systolic blood  pressure (mmHg) 123.1 ± 18.7 118.2 ± 15.6 117.0 ± 14.8 NS 
HbA1C (%) 6.95 ± 1.20 5.90  ± 0.58 6.45 ± 0.79 NS 
LDL-cholesterol (mmol/l) 3.91 ± 0.86 3.03 ± 0.65 3.47 ± 0.87 <0.001 
HDL-cholesterol (mmol/l) 1.0 ± 0.36 1.04 ± 0.29 1.05 ± 0.34 NS 
Total cholesterol (mmol/l) 4.77 ± 0.91 5.33 ± 0.74 4.95 ± 0.85 0.001 
Triglyceride (mmol/l) 1.43 ± 0.57 1.38 ± 0.65 1.22 ± 0.49 NS 
Glucose (mmol/l) 6.75 ± 2.81 5.98 ± 2.43 6.25 ± 2.60 NS 
MDA (µmol/l) 2.73 ± 1.01 2.03 ± 0.67 1.90 ± 0.63 <0.001 
CML (ng/ml) 513.9 ± 111.4 412.3 ± 58.8 431.1 ± 43.9 <0.001 
 
Note: One-way ANOVA was used for statistical analysis, values are expressed as mean ± SD. *Differences are considered significant if P <0.05. NS; 
the difference is not significant. 
  
 
 
Table 2. Bivariate and multivariate correlation analysis between CML and clinical parameters in the ethnic groups. 
 
 
Bivariate correlation  Multivariate correlation 
r P Value  β P Value 
Malays 
MDA  0.40 0.001  0.325 0.003 
LDL 0.43 <0. 001  0.356 0.001 
HbA1c 0.32 0.009  0.255 0.018 
       
Chinese 
MDA  0.07 0.62  0.006 0.967 
LDL 0.15 0.28  0.026 0.874 
HbA1c 0.29 0.04  0.277 0.101 
       
Indians 
MDA  0.33 0.013  0.30 0.017 
LDL 0.32 0.016  0.33 0.015 
HbA1c 0.03 0.80  0.14 0.26 
  
 
 
analyses were carried out using Kruskall–Wallis test. Correlations 
between the parameters were analyzed by bivariate and 
multivariate correlation analysis. Statistical computations were 
calculated using SPSS 11.5 for Windows software (SPSS Inc, 
Chicago, IL, USA). A P value of <0.05 was considered statistically 
significant. 
 
 
RESULTS  
 
Demographic and biochemical characteristics of the 
study groups 
 
Demographic and biochemical characteristics of the 3 
ethnic groups are presented in Table 1. The mean ages 
of the Malay, Chinese, and Indian populations were: 
45.1±15.1, 44.9±18.8, and 47.3±18.4 years, respectively. 
As Table 1 shows, Malays had significantly higher levels 
of   CML   (P<0. 001),  MDA  (P<0.001),  total  cholesterol 
(P<0.001), and LDL (P<0.001) than the Indian and 
Chinese patients. Fasting blood glucose and HDL-
cholesterol levels were not significantly different among 
the three groups. Although a statistical significance was 
not observed in the levels of HbA1c among the study 
groups, Post-hoc analysis revealed higher levels in 
Malays than in the Indian and Chinese subjects; P=0.009 
vs. P= 0.006, respectively.  
 
 
Correlations between CML and biochemical 
parameters in the study subgroups 
 
Table 2 shows both bivariate and multivariate correlations 
between CML and different biochemical parameters in 
the three ethnic groups. Bivariate correlation analysis 
revealed that serum CML levels were significantly 
correlated with MDA in both Malay  (r = 0.40,  P = 0. 001)  
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Figure 1. Relationship between CML and MDA in Malay (A) and Indian (B) diabetic patients.  
 
 
 
and Indian (r = 0.33, P = 0. 013) diabetic subjects as 
shown in Figures 1A and B, respectively. In the 
meantime, a positive and significant correlation was 
observed between CML and LDL cholesterol among 
Malay and Indian individuals; r = 0.43, P < 0 .001 vs. r = 
0.32., P <0.016, respectively. However, in the Chinese 
population, neither serum levels of MDA nor LDL were 
correlated with CML concentrations; r = 0.07, P = 0.62 vs. 
r = 0.15, P = 0.28, respectively. Additionally, only the 
Malay subjects had positive correlations between CML 
and HbA1c as confirmed by multivariate correlation 
analysis (Table 2). 
 
 
DISCUSSION 
 
N
ε
-(carboxymethyl)lysine is a glycoxidation product and 
its accumulation on tissue proteins has been contributed 
to the pathogenesis of many of the diabetic complications 
(Ahmed et al.,  2007;  Araki  et  al.,  1992;  Uesugi  et  al., 
2000). In addition, it has been shown that CML is 
implicated in the impaired uptake of LDL leading to 
coronary artery diseases seen in type 2 diabetes (Ahmed 
et al., 2008). Malondialdehyde is a lipoxidation end 
product and is well characterized during the oxidation of 
polyunsaturated fatty acids on LDL (Requena et al., 
1996). Although some researchers suggested that 
glucose may enhance free radical formation (Hicks et al., 
1988; Mullarkey et al., 1990), the time course of the 
formation of lipoxidation end products indicates 
thatoxidative modification occurs after more advanced 
glycation reactions have taken place. The present study 
revealed that CML levels and MDA were significantly 
elevated in Malay subjects when compared to those of 
the Indian or Chinese populations. This implies that over 
time modest increases in glucose and LDL concen-
trations can result in a significant increase of CML and 
lipid peroxidation products on long-lived proteins, and this 
might be affected by the lifestyle as well as the eating 
habits. 
 
 
 
 
Malays had the greatest incidence of high LDL and 
HbA1c followed by the Indians and Chinese. Compared 
with the Chinese, the Malays and Indians were more 
likely to have a positive family history of diabetes mellitus. 
In addition, Indian patients were less likely to have 
associated hypertension than Malays. Correlation 
between CML and other clinical parameters showed that, 
the higher levels of CML were associated with the eleva-
tion of both MDA and LDL, which implies an enhanced 
oxidation process in the Malay and Indians ethnic groups. 
There have been no previous reports comparing Malays, 
Indians, and Chinese regarding the aforementioned 
health aspects. There are reports of enhancement of both 
oxidation and AGE-modification of LDL in diabetic 
patients (Bucala et al., 1993; 1994). Our results suggest 
that, in the Malaysian population, levels of HDL 
cholesterol correlated with MDA levels, indicating that 
HDL cholesterol was also subjected to oxidation due to a 
chronic increase in the glucose levels.  This is in line with 
the previous reports which revealed that, HDL mole-cules 
are susceptible to structural modifications mediated by 
various mechanisms including oxidation and glycation. 
For example, Ferretti et al. (2001) have shown significant 
increase in TBARS and conjugated dienes in HDL 
incubated with glucose as compared to control HDL, 
indicating that that lipid peroxidation and HDL glycation 
are associated processes. Another study demonstrated 
that glycoxidized HDL (Gly-ox-HDL) affect the functions 
of endothelial cells (EC). Therefore, HDL exposure to 
hyperglycemic conditions could contribute to the 
accelerated atherosclerosis in diabetic patients 
(Matsunaga et al., 2001).  
Ethnic differences in glycoxidation and lipid peroxi-
dation products might be due to environmental, genetic, 
and/or dietary factors. It is also possible that the risk 
factors for diabetes-associated atherosclerosis could 
differ considerably between ethnic groups because of 
differences in diet, physical activity, body weight, and 
lifestyle variations. Information on ethnic differences in 
the risk factors of T2DM and its complications is, there-
fore, useful for describing the diabetes related health 
burden in a population as well as for the planning of 
practical preventive strategies (Bucala et al., 1993; 1994; 
Jarrett et al., 1982). In the NHMS III, diabetic patients 
showed different types of complications such as lower 
limb amputation (4.3%), strokes (3.4%), and kidney 
disorders (1.6%). As a result of the fact that, 
environmental changes can alter the tendency of patients 
to T2DM complications, knowledge of ethnic differences 
can be used to delay the onset of complications, and 
enable doctors to manage their patients better by using 
strategies for lifestyle changes such as dietary advice 
and cooking tips.   
 
 
ACKNOWLEDGEMENTS 
 
This   study    was   supported    financially   by   Intensive  
Ahmed et al.          1961 
 
 
 
Research in Priorities Area (IRPA), Ministry of Science 
and Technology, Malaysia. (Project grant IRPA No. 36-
02-03-6020) and the University of Malaya, (PPP No. 
P0193/2006A). 
 
 
REFERENCES 
 
Ahmed KA, Muniandy S, Ismail IS (2007). Role of N
ε
-
(carboxymethyl)lysine in the development of ischemic heart disease 
in type 2 diabetes mellitus. J. Clin. Biochem. Nutr., 41(2): 97-105. 
Ahmed KA, Muniandy S, Ismail IS (2008). Implications of N
ε
-
(carboxymethyl)lysine in altered metabolism of low density 
lipoproteins in patients with type 2 diabetes and coronary artery 
disease. J. Med. Sci., 8: 152-161. 
Ali O, Khalid BAK, Tan TT, Khalid BA, Wu LL, Ng ML (1993). 
Prevalence of NIDDM and impaired glucose tolerance in Aborigines 
and Malays in Malaysia and their relationship to sociodemographic, 
health and nutritional factors. Diabetes Care, 16: 68-75. 
Araki N, Ueno N, Chakrabarti B, Morino Y, Horiuchi S (1992). 
Immunochemical evidence for the presence of advanced glycation 
end products in human lens proteins and its positive correlation with 
aging. J. Biol. Chem., 267(15): 10211-10214. 
Bierhaus A, Hofmann MA, Ziegler R, Nawroth PP (1998). AGEs and 
their interaction with AGE-receptors in vascular disease and diabetes 
mellitus. I. The AGE concept. Cardiovasc. Res., 37(3): 586-600. 
Brownlee M (2000). Negative consequences of glycation. Metabolism, 
49(2Suppl 1): 9-13. 
Brownlee M (2001). Biochemistry and molecular cell biology of diabetic 
complications. Nature, 414(6865): 813-820. 
Bucala R, Makita Z, Koschinsky T, Cerami A, Vlassara H (1993). Lipid 
advanced glycosylation: pathway for lipid oxidation in vivo. Proc. Natl. 
Acad. Sci. USA, 90: 6434-6438. 
Bucala R, Makita Z, Koschinsky T, Cerami A, Vlassara H (1994). 
Modification of low density lipoprotein by advanced glycation end 
products contributes to the dyslipidemia of diabetes and renal 
insufficiency. Proc. Natl. Acad. Sci. USA, 91: 9441-9445. 
Ferretti G, Bacchetti T, Marchionni C, Caldarelli L, Curatola G (2001). 
Effect of glycation of high density lipoproteins on their 
physicochemical properties and on paraoxonase activity. Acta 
Diabetol., 38: 163-169. 
Friedewald WT, Levy RI, Fredrickson DS (1972). Estimation of the 
concentration of low-density lipoprotein cholesterol in plasma, without 
use of the preparative ultracentrifuge. Clin. Chem., 18(6): 499-502. 
Gu K, Cowie CC, Harris MI (1998). Mortality in adults with and without 
diabetes in a national cohort of the U.S. population, 1971-1993. 
Diabetes Care, 21: 1138-1145. 
Harris MI, Flegal KM, Cowie CC, Eberhardt MS, Goldstein DE, Little 
RR, Wiedmeyer HM, Byrd-Holt DD (1998). Prevalence of diabetes, 
impaired fasting glucose, and impaired glucose tolerance in U.S. 
adults: The Third National Health and Nutrition Examination Survey, 
1988-1994. Diabetes Care, 28: 518-524.  
Hicks M, Delbridge L, Yue DK, Reeve TS (1988). Catalysis of lipid 
peroxidation by glucose and glycosylated collagen. Biochem. 
Biophys. Res. Commun., 151(2): 649-655. 
Huxley R, Barzi F, Woodward M (2006). Excess risk of fatal coronary 
heart disease associated with diabetes in men and women: meta-
analysis of 37 prospective cohort studies. BMJ., 332(7533): 73-78. 
Ikeda K, Higashi T, Sano H, Jinnouchi Y, Yoshida M, Araki T, Ueda S, 
Horiuchi S (1996). N
ε
-(carboxymethyl)lysine protein adduct is a major 
immunological epitope in proteins modified with advanced glycation 
end products of the Maillard reaction. Biochem., 35(24): 8075-8083. 
Jarrett RJ, McCartney P, Keen H (1982). The Bedford survey: ten year 
mortality rates in newly diagnosed diabetics, borderline diabetics and 
normoglycaemic controls and risk indices for coronary heart disease 
in borderline diabetics. Diabetology, 22(2): 79-84. 
King H, Aubert RE, Herman WH (1998). Global burden of diabetes, 
1995–2025: Prevalence, numerical estimates, and projections. 
Diabetes Care, 21: 1414-1431. 
Kunst A, Draeger B, Ziegenhorn J (1983). UV-method with hexokinase 
and glucose-6-phosphate dehydrogenase. In: Bergmeyer HU (ed)  
1962            Sci. Res. Essay 
 
 
 
Methods of Enzymatic Analysis. Verlag Chemie: Deerfield, FL., pp. 163-
172. 
Laakso M (1999). Hyperglycemia and cardiovascular disease in type 2 
diabetes. Diabetes, 48(5): 937-942. 
Lim TO, Ding LM, Zaki M, Suleiman AB, Kew ST, Ismail M, Maimunah 
AH, Rugayah B, Rozita H (2000). Distribution of blood total 
cholesterol in a national sample of Malaysian adults. Med. J. 
Malaysia, 55: 78-89. 
Lowe LP, Liu K, Greenland P, Metzger BE, Dyer AR, Stamler J (1997). 
Diabetes, asymptomatic hyperglycemia, and 22-year mortality in 
black and white men. The Chicago Heart Association Detection 
Project in Industry Study. Diabetes Care, 20: 163-169. 
Makita Z, Vlassara H, Cerami A, Bucala R (1992). Immunochemical 
detection of advanced glycosylation end products in vivo. J. Biol. 
Chem., 267(8): 5133-5138. 
Matsunaga T, Iguchi K, Nakajima T, Koyama I, Miyazaki T, Inoue I, 
Kawai S, Katayama S, Hirano K, Hokari S, Komoda T (2001). 
Glycated high-density lipoprotein induces apoptosis of endothelial 
cells via a mitochondrial dysfunction. Biochem. Biophys. Res. 
Commun., 287: 714-720. 
Mullarkey CJ, Edelstein D, Brownlee M (1990). Free radical generation 
by early glycation products: a mechanism for accelerated 
atherogenesis in diabetes. Biochem. Biophys. Res. Commun., 
173(3): 932-939. 
Ohkawa H, Ohishi N, Yagi K (1979). Assay for lipid peroxides in animal 
tissues by thiobarbituric acid reaction. Anal. Biochem., 95(2): 351-
358. 
Pan CY, So WY, Khalid BAK, Mohan V, Thai AC, Zimmet P, Cockram 
CS, Jorgensen LN, Yeo JP, The ASDIAB Study Group (2004). 
Metabolic, immunological and clinical characteristics in newly 
diagnosed Asian diabetes patients aged 12-40 years. Diabet. Med., 
21: 1007-1013. 
Public Health Institute (1986). Report of the First National Health and 
Morbidity Survey (NHMS I). Ministry of Health, Malaysia. 
Public Health Institute (1996). Report of the Second National Health and 
Morbidity Survey (NHMS II). Ministry of Health, Malaysia.  
Public Health Institute (2006). Report of the Third National Health and 
Morbidity Survey (NHMS III). Ministry of Health, Malaysia. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Requena JR, Fu MX, Ahmed MU, Jenkins AJ, Lyons TJ, Thorpe SR 
(1996). Lipoxidation products as biomarkers of oxidative damage to 
proteins during lipid peroxidation reactions. Nephrol. Dial. 
Transplant., 11(Suppl 5): 48-53. 
Saydah SH, Loria CM, Eberhardt MS, Brancati FL (2001). Subclinical 
states of glucose intolerance and risk of death in the U.S. Diabetes 
Care, 24: 447-453. 
Schernthaner G (1996). Cardiovascular mortality and morbidity in type-2 
diabetes mellitus. Diabet. Res. Clin. Pract., 31(suppl): S3-S13. 
Shaw JE, Hodge AM, De Courten M, Chitson P, Zimmet PZ (1999). 
Isolated post-challenge hyperglycaemia as a risk factor for mortality. 
Diabetol., 42: 1050-1054. 
Sicree R, Shaw J, Zimmet P (2003). The global burden of diabetes, 
Diabetes and impaired glucose tolerance: prevalence and 
projections. In: Gan D (ed) Diabetes Atlas, 2nd ed. International 
Diabetes Federation, Brussels, pp. 15-71. 
Tsaknis J, Lalas S, Tychopoulos V, Hole M, Smith G (1998). Rapid 
high-performance liquid chromatographic method of determining 
malondialdehyde for evaluation of rancidity in edible oils. Analyst, 
123(2): 325-327. 
Uesugi N, Sakata N, Nagai R, Jono T, Horiuchi S, Takebayashi S 
(2000). Glycoxidative modification of AA amyloid deposits in renal 
tissue. Nephrol. Dial. Transplant, 15(3): 355-365. 
Wei M, Gaskill SP, Haffner SM, Stern MP (1998). Effects of diabetes 
and level of glycemia on all-cause and cardiovascular disease 
mortality. The San Antonio Heart Study. Diabet. Care, 21: 1167-1172. 
Wells-Knecht KJ, Brinkmann E, Wells-Knecht MC, Litchfield JE, Ahmed 
MU, Reddy S, Zyzak DV, Thorpe SR, Baynes JW (1996). New 
biomarkers of Maillard reaction damage to proteins. Nephrol. Dial. 
Transplant, 11(Suppl 5): 41-47. 
Wolff SP, Jiang ZY, Hunt JV (1991). Protein glycation and oxidative 
stress in diabetes mellitus and ageing. Free Radic. Biol. Med., 10(5): 
339-352. 
WHO (1999). Definition, diagnosis and classification of diabetes mellitus 
and its complications: Report of a WHO Consultation, WHO, Geneva.  
Zimmet P, Alberti KG, Shaw J (2001). Global and societal implications
of the diabetes epidemic. Nature, 414(6865): 782-787. 
 
 
 
 
 
 
 
 
 
 
 
